Latest Mucositis Stories
Expanding Product Offerings; Building IP Portfolio; Seeking Global Marketing Partners NEW YORK, April 1, 2014 /PRNewswire/ --
Company Seeking Global Marketing Partners for its Proprietary Vitamin B-12 Drug Delivery Technology NEW YORK, March 26, 2014 /PRNewswire/ --
PRINCETON, N.J., March 26, 2014 /PRNewswire/ -- Soligenix, Inc.
Leveraging Proprietary Mucoadhesive Polymer Hydrogel Technology to Expand Product Offerings; Seeking Global Marketing Partners NEW YORK, March 21, 2014 /PRNewswire/ --
NEW YORK, March 11, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) today announced that it had entered
Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score
MILAN, February 17, 2014 /PRNewswire/ -- BMG Pharma S.r.l.
PRINCETON, N.J., Jan. 6, 2014 /PRNewswire/ -- Soligenix, Inc.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).